V Wealth Management LLC Has $3.19 Million Holdings in Centene Corp (CNC)

V Wealth Management LLC trimmed its holdings in shares of Centene Corp (NYSE:CNC) by 20.0% during the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 22,095 shares of the company’s stock after selling 5,516 shares during the period. Centene makes up approximately 1.5% of V Wealth Management LLC’s investment portfolio, making the stock its 8th largest holding. V Wealth Management LLC’s holdings in Centene were worth $3,194,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds have also modified their holdings of the company. BlackRock Inc. increased its holdings in shares of Centene by 15.5% during the second quarter. BlackRock Inc. now owns 15,847,653 shares of the company’s stock valued at $1,952,589,000 after purchasing an additional 2,122,661 shares during the period. Wells Fargo & Company MN increased its holdings in shares of Centene by 5.2% during the second quarter. Wells Fargo & Company MN now owns 3,309,046 shares of the company’s stock valued at $407,707,000 after purchasing an additional 162,597 shares during the period. Northern Trust Corp grew its holdings in Centene by 15.6% during the second quarter. Northern Trust Corp now owns 2,306,279 shares of the company’s stock worth $284,156,000 after acquiring an additional 311,998 shares during the period. Bank of America Corp DE grew its holdings in Centene by 3.9% during the second quarter. Bank of America Corp DE now owns 2,145,126 shares of the company’s stock worth $264,301,000 after acquiring an additional 81,444 shares during the period. Finally, Jennison Associates LLC grew its holdings in Centene by 47.6% during the second quarter. Jennison Associates LLC now owns 2,113,026 shares of the company’s stock worth $260,346,000 after acquiring an additional 681,847 shares during the period. 89.98% of the stock is currently owned by institutional investors.

NYSE:CNC opened at $131.95 on Wednesday. The stock has a market cap of $26.13 billion, a P/E ratio of 26.23, a PEG ratio of 1.18 and a beta of 0.82. Centene Corp has a 52-week low of $90.07 and a 52-week high of $148.24. The company has a current ratio of 1.03, a quick ratio of 1.03 and a debt-to-equity ratio of 0.59.



Centene (NYSE:CNC) last released its quarterly earnings results on Tuesday, October 23rd. The company reported $1.79 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.77 by $0.02. Centene had a return on equity of 14.42% and a net margin of 1.58%. The business had revenue of $16.18 billion during the quarter, compared to analyst estimates of $15.93 billion. During the same quarter last year, the company posted $1.35 EPS. Centene’s revenue for the quarter was up 36.0% on a year-over-year basis. Sell-side analysts anticipate that Centene Corp will post 7.05 earnings per share for the current fiscal year.

In related news, Director Robert K. Ditmore sold 15,000 shares of the stock in a transaction on Thursday, October 25th. The stock was sold at an average price of $129.24, for a total value of $1,938,600.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Christopher D. Bowers sold 3,800 shares of the stock in a transaction on Monday, September 10th. The shares were sold at an average price of $145.55, for a total value of $553,090.00. The disclosure for this sale can be found here. Insiders sold a total of 35,800 shares of company stock valued at $4,957,590 in the last quarter. 3.00% of the stock is currently owned by corporate insiders.

A number of research analysts recently issued reports on the company. Credit Suisse Group lifted their target price on Centene from $134.00 to $152.00 and gave the stock a “neutral” rating in a report on Tuesday, September 4th. Morgan Stanley lifted their target price on Centene from $138.00 to $175.00 and gave the stock an “overweight” rating in a report on Wednesday, September 5th. Oppenheimer lifted their target price on Centene from $146.00 to $158.00 and gave the stock an “outperform” rating in a report on Tuesday, October 2nd. MED lifted their target price on Centene from $146.00 to $158.00 and gave the stock an “outperform” rating in a report on Tuesday, October 2nd. Finally, Zacks Investment Research raised Centene from a “sell” rating to a “hold” rating in a report on Thursday, October 4th. Three research analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company’s stock. The company presently has an average rating of “Buy” and a consensus price target of $151.67.

Centene Company Profile

Centene Corporation operates as a diversified and multi-national healthcare enterprise that provides programs and services to under-insured and uninsured individuals in the United States. It operates through two segments, Managed Care and Specialty Services. The Managed Care segment offers health plan coverage to individuals through government subsidized programs, including Medicaid, the State children's health insurance program, long-term care, foster care, and dual eligible individual, as well as aged, blind, or disabled programs.

Featured Story: What are the risks of holding treasury bonds?

Want to see what other hedge funds are holding CNC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Centene Corp (NYSE:CNC).

Institutional Ownership by Quarter for Centene (NYSE:CNC)

Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply